Evan J Zasowski

机构：Pfizer (United States) · ORCID：0000-0002-2595-1860

发表论文 82 篇 · 总被引 2315 次 · h-index 22

代表论文

Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections (2019 · Open Forum Infectious Diseases · 被引 138)
Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections (2020 · International Journal of Antimicrobial Agents · 被引 116)
A Systematic Review of the Effect of Delayed Appropriate Antibiotic Treatment on the Outcomes of Patients With Severe Bacterial Infections (2020 · CHEST Journal · 被引 114)
Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study (2019 · Clinical Infectious Diseases · 被引 101)
Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments (2019 · Open Forum Infectious Diseases · 被引 94)
Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections (2020 · Antimicrobial Agents and Chemotherapy · 被引 55)